Organto Foods Posts Record H1 Sales of $53.3M, Up 73%, With Positive EBITDA
OGOFF sits 22% above its 52-week low of $0.25.
Summary
Organto Foods reported record first half 2026 results with sales up 73% to $53.3 million and positive EBITDA of $0.5 million, a swing from a loss of $0.2 million a year earlier. The company also highlighted a strong balance sheet with $15.3 million in working capital and no long-term debt, supported by an expanded Rabobank facility and a $5.8 million early warrant exercise. Management emphasized progress on strategic initiatives including new customers, geographies, and an AI-powered operational transformation. The annualized sales run rate now exceeds $100 million, a key milestone. This is the first disclosure of these results and should be viewed as a material positive update for the company.
At the time of this announcement, OGOFF was trading at $0.30 on OTC in the Trade & Services sector, with a market capitalization of approximately $45.5M. The 52-week trading range was $0.25 to $0.91. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.